At RAMJA Genosensor, our mission is to transform global healthcare by enabling rapid, accurate, and affordable diagnosis of infections and antimicrobial resistance (AMR). Using our patented paper-based DNA biosensor technology, we empower medical professionals to identify life-threatening infections and resistance profiles within just 90 minutes—helping deliver the right antibiotic at the right time. Driven by a personal story and a deep commitment to saving lives, we aim to bridge the critical time gap in diagnostics, reduce antibiotic misuse, and combat the growing threat of superbugs—making advanced diagnostics accessible to every corner of the world.

RAMJA Genosensor was born from a deeply personal loss and a powerful determination to change the future of infection diagnostics. In 2014, our founder lost her father to an undetected infection during cancer treatment. The infection report arrived after his passing—a devastating moment that exposed the critical delay in conventional diagnostic timelines. This life-altering experience became the driving force behind our innovation. Motivated to bridge the deadly gap between symptom onset and accurate diagnosis, she set out to develop a technology that could detect infections and antimicrobial resistance (AMR) in under 90 minutes—instead of waiting 3 to 4 days. After years of research, development, and testing, RAMJA Genosensor emerged as a groundbreaking solution incubated at IIT Delhi. Our name, RAMJA, is a tribute—blending the names of the founder and her father: Ramesh + Pooja. Today, we proudly offer India’s first patented paper-based DNA genosensor, a transformative MedTech innovation designed to save lives by delivering the right antibiotic at the right time.

At RAMJA Genosensor, we offer rapid, affordable, and accurate diagnostic solutions to detect infections and antimicrobial resistance (AMR) within 90 minutes. Our patented, paper-based DNA biosensor technology works with all biological fluids and supports critical clinical decisions with speed and precision.